Akèy › Tit travay › Senior Statistical Programmer
Senior Statistical Programmer: Salè H-1B
307 aplikasyon kondisyon travay te itilize tit travay Senior Statistical Programmer. Salè baz medyàn ofri $120,867; mwatye mitan $108,123–$131,475.
Demann (LCA)307
Salè medyan ofri$120,867
Mwatye salè yo$108,123–$131,475
10yèm–90yèm pousantaj$91,162–$142,574
Avoka imigrasyon, rekritè oswa anplwayè? Mete sèvis ou an tèt paj sa a — $99 pou 30 jou →
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|
| IQVIA RDS Inc. | 49 | $126,836 |
| Cytel Inc. | 36 | $125,000 |
| Gilead Sciences, Inc. | 13 | $110,800 |
| Fortrea Inc. | 11 | $117,010 |
| Safety & Efficacy IT Solutions Inc. | 10 | $91,450 |
| Ephicacy Consulting Group, Inc | 10 | $130,000 |
| Parexel International LLC | 9 | $131,532 |
| TechData Service Company LLC | 9 | $139,000 |
| Skill Buddy Inc | 9 | $92,498 |
| Intone Networks, Inc. | 8 | $110,000 |
| Pfizer Inc. | 8 | $109,366 |
| Seagen Inc. | 6 | $122,000 |
| Tekorion Inc. | 6 | $105,000 |
| Episdata Inc | 6 | $125,694 |
| Element Technologies Inc | 5 | $96,000 |
| TruMinds Technologies Inc | 5 | $111,842 |
| Calsoft Labs Inc | 5 | $86,500 |
| Labcorp Drug Development Inc. | 4 | $103,431 |
| Regeneron Pharmaceuticals, Inc. | 4 | $122,686 |
| Vertex Pharmaceuticals Incorporated | 4 | $109,666 |
| Lexitas Pharma Services Inc. | 4 | $124,383 |
| Nexpro Technologies, Inc | 4 | $118,102 |
| Jazz Pharmaceuticals, Inc. | 4 | $108,000 |
| Talentech Consulting LLC | 4 | $108,784 |
| Maxisit, Inc. | 4 | $137,670 |
| Syneos Health, LLC | 3 | $87,922 |
| Career Quench Technologies LLC | 3 | $63,066 |
| Fred Hutchinson Cancer Center | 3 | $140,471 |
| Fortrea Inc. f/k/a LabCorp Drug Development Inc. | 2 | $119,500 |
| Axio Research, LLC | 2 | $119,389 |
| ImmunityBio, Inc. | 2 | $131,774 |
| Protagonist Therapeutics, Inc. | 2 | $162,500 |
| Alnylam US, Inc. | 2 | $147,500 |
| Redbock LLC | 2 | $168,480 |
| Springworks Therapeutics Operating Company | 2 | $158,000 |
| Experis US, LLC | 2 | $76,918 |
| Sriven Info Inc | 2 | $111,999 |
| Advanced Clinical LLC | 2 | $132,612 |
| Biorasi LLC | 2 | $84,698 |
| Exelixis, Inc | 2 | $148,541 |
| Sunovee Inc | 2 | $95,000 |
| Arrowhead Pharmaceuticals, Inc. | 2 | $120,000 |
| Virtue America, LLC | 2 | $138,320 |
| BeiGene USA, Inc. | 1 | $136,000 |
| Sun-IT Solutions Inc. | 1 | $130,000 |
| Quadtree Technologies Inc | 1 | $76,000 |
| Service Oriented Solutions LLC | 1 | $88,005 |
| Pharmaron US Clinical Services, Inc. | 1 | $89,301 |
| Sarah Cannon Research Institute Holdings, LLC | 1 | $97,454 |
| Fortrea, Inc. (formely d/b/a LabCorp Drug development, Inc.) | 1 | $120,000 |
| Kairas Tech LLC | 1 | $91,000 |
| Roche Molecular Systems, Inc. | 1 | $119,330 |
| Brainy IT Solutions LLC | 1 | $139,360 |
| Cloudsol Technologies, Inc | 1 | $78,624 |
| Softworld, LLC | 1 | $100,000 |
| ICF Macro, Inc. | 1 | $79,940 |
| Arsphere Infotek, Inc. | 1 | $141,856 |
| System One Holdings, LLC | 1 | $132,246 |
| MorphoSys US Inc. | 1 | $152,842 |
| Clymb Clinical LLC | 1 | $100,000 |
Pa nivo salè
| Nivo revni | Salè medyan |
|---|
| Nivo I (antre) | $97,454 |
| Nivo II (kalifye) | $114,546 |
| Nivo III (eksperyans) | $123,879 |
| Nivo IV (plen kompetans) | $136,448 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|
| FY2023 | 83 | $116,480 |
| FY2024 | 100 | $122,000 |
| FY2025 | 70 | $125,000 |
| FY2026 | 41 | $122,128 |
Vil yo
- Bothell, WA13
- Cary, NC9
- Durham, NC9
- Morrisville, NC8
- Apex, NC8
- McKinney, TX8
- Leander, TX7
- Foster City, CA6
- Iselin, NJ6
- Princeton, NJ5
- Charlotte, NC5
- King of Prussia, PA5
- Cumming, GA5
- North Wales, PA5
- Round Rock, TX4
- Overland Park, KS4
- Cambridge, MA4
- Fuquay Varina, NC4
- Aubrey, TX4
- Buford, GA3
- Irving, TX3
- Irvine, CA3
- Piscataway, NJ3
- Roundrock, TX3
- Edison, NJ3
- Hutto, TX3
- Chesterfield, NJ3
- Prosper, TX3
- Philadelphia, PA3
- Lewis Center, OH2
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).